Prediction of survival outcome using Chuang's prognostic scale in metastatic breast cancer
Open Access
- 1 January 2021
- journal article
- research article
- Published by Scientific Scholar in Indian Journal of Palliative Care
- Vol. 27 (1), 43-46
- https://doi.org/10.4103/ijpc.ijpc_97_20
Abstract
Background: For physicians and patients, survival estimation is vital for the treatment plan, especially with frequent use of new therapeutic agents in metastatic breast cancer (MBC). The Chuang's Prognostic Scale (CPS) is a validated prognostic score that may be useful in the avoidance of unnecessary palliative systemic treatment. Aim: The present study aimed to evaluate the CPS in survival prediction in patients with MBC after at least two lines of palliative systemic chemotherapy protocols (PSCPs). Methods: CPS was prospectively measured in 221 patients with MBC. The total score ranged from 0 to 8.5; the lower score refers to a good prognosis. The survival assessment was made by the Kaplan–Meier curve and the survival difference among the groups was estimated by log-rank test. Results: Using the cutoff value of CPS 5.7, the patients were classified into two groups: Group A had score ≤5.7 (174 patients, 78.7%) and Group B had CPS score >5.7 (47 patients, 21.3%). About 86.2% of the patients in Group A survived >3 months (median survival was 165 days, 95% confidence interval [CI]: 77–261) compared with 21.3% of patients survived in Group B (median survival was 81 days, 95% CI: 55–123) (P = 0.00). The sensitivity, specificity, positive predictive value, and negative predictive value were 97.6% (95% CI: 87.4–99.9), 98.3% (95% CI: 95.2–99.7), 93.2% (95% CI: 81.6–97.7), and 99.4% (95% CI: 96.2–99.9), respectively, for the 3-month mortality prediction. Conclusion: CPS could be helpful in estimating the survival outcome in patients with MBC who received at least two PSCPs.Keywords
This publication has 11 references indexed in Scilit:
- Aggressive care at the end of life; Where are we?Indian Journal of Palliative Care, 2019
- Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: A systematic review and meta-analysisEuropean Journal of Cancer, 2018
- The use of the Chuang′s prognostic scale to predict the survival of metastatic colorectal cancer patients receiving palliative systemic anticancer therapyIndian Journal of Palliative Care, 2016
- End-of-life palliative chemotherapy: Where do we stand?Journal of the Egyptian National Cancer Institute, 2015
- Simple Prognostic Model for Patients With Advanced Cancer Based on Performance StatusJournal of Oncology Practice, 2014
- Nomogram to Predict Cycle-One Serious Drug-Related Toxicity in Phase I Oncology TrialsJournal of Clinical Oncology, 2014
- Predicting life expectancy in patients with advanced incurable cancer: a reviewThe Journal of Supportive Oncology, 2013
- Prediction of In-Hospital Mortality of Patients With Advanced Cancer Using the Chuang Prognostic ScoreAmerican Journal of Hospice and Palliative Medicine®, 2012
- Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scaleJournal of Pain and Symptom Management, 2004
- Discrepancies Between Patient and Physician Estimates for the Success of Stem Cell TransplantationJAMA, 2001